Previous Close | 0.2600 |
Open | 0.2700 |
Bid | 0.2450 x N/A |
Ask | 0.2600 x N/A |
Day's Range | 0.2450 - 0.2700 |
52 Week Range | 0.1900 - 3.9000 |
Volume | |
Avg. Volume | 16,115 |
Market Cap | 4.783M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining by more than 350 points on Friday. The Dow traded up 0.82% to 44,228.50 while the NASDAQ rose 0.14% to 18,998.27. The S&P 500 also rose, gaining, 0.31% to ...
Tuspetinib will be assessed as a frontline triplet therapy for newly diagnosed AML patients.